PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 18 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,000 | 0.0% | 18,000 | 0.0% | 0.01% | +10.0% |
| Q3 2017 | $18,000 | 0.0% | 18,000 | 0.0% | 0.01% | -9.1% |
| Q2 2017 | $18,000 | 0.0% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $18,000 | 0.0% | 18,000 | 0.0% | 0.01% | -8.3% |
| Q4 2016 | $18,000 | +5.9% | 18,000 | 0.0% | 0.01% | +9.1% |
| Q3 2016 | $17,000 | 0.0% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $17,000 | +6.2% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $16,000 | – | 18,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|